Endoscopic Biopsy vs. Non-Invasive Tests for H. pylori Diagnosis
Diagnosing H. pylori infection can be accomplished through invasive endoscopic biopsy methods or non-invasive tests, each with advantages and limitations. The H. Pylori Test market evaluates these diagnostic approaches to inform clinical decision-making.
Endoscopic biopsy allows direct visualization and collection of gastric tissue for rapid urease testing, histology, culture, and molecular analysis. It provides definitive diagnosis and antibiotic susceptibility data but is costly, invasive, and requires specialized expertise.
Non-invasive tests, including urea breath tests, stool antigen tests, and serology, offer safer, more accessible alternatives with good sensitivity and specificity. They are preferred for initial screening and post-treatment monitoring.
Clinical context, patient risk, resource availability, and test purpose determine the choice of diagnostic modality, balancing accuracy, invasiveness, and cost.